Neurocrine Biosciences | NBIX - Action





Action Changement Date
AbbVie USD 5.13B 78M 2026-06
Acadia Pharmaceuticals USD 108.67M 77.1M 2026-06
Agios Pharmaceuticals USD 35.75M 665K 2026-06
ALKERMES USD 298.96M 37.75M 2026-06
Alnylam Pharmaceuticals USD 97.11M 103.04M 2026-06
Amgen USD 6.22B 34M 2026-06
Biogen USD 2.38B 435.3M 2026-06
BioMarin Pharmaceutical USD 1.78B 509.3M 2026-06
Cytokinetics USD 380K 226K 2026-06
Exelixis USD 28.73M 2.12M 2026-06
Gilead Sciences USD 1.91B 140M 2026-03
Halozyme Therapeutics USD 137.14M 18.33M 2026-06
Incyte USD 112.54M 3.08M 2026-06
Ionis Pharmaceuticals USD 50.83M 45.28M 2026-06
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Neurocrine Biosciences USD 104.2M 39.7M 2026-06
Pfizer USD 9.94B 722M 2026-06
Regeneron Pharmaceuticals USD 3.08B 19.3M 2026-06
Repligen USD 186.6M 7.35M 2026-06
Rigel Pharmaceuticals USD 13.3M 2.88M 2025-09
Sarepta Therapeutics USD 904.27M 96.84M 2026-06
Teva Pharmaceutical Industries USD 3.18B 3M 2026-03
Ultragenyx Pharmaceutical USD 59M 4M 2026-06
Vertex Pharmaceuticals USD 1.77B 1.6M 2026-06